Less Adolescents May Use STD Services Fearing Parents Could Find Out
March 16th 2017CDC researchers examine STD services and confidentiality issues among individuals between 15 and 25 years of age and find that not spending time alone with a healthcare provider, without a parent in the room, may limit use of STD services for some youths.
Study Finds Nurse-Delivered Intervention Program Significantly Improves HIV-Treatment Adherence
March 16th 2017Adherence with HIV therapy regimens remains difficult for some patients. Nurse-delivered interventions can increase adherence, reduce disease costs, and extend the lifespan in an HIV-infected population.
Patients with Beta-Lactam Allergy Need Unique Antimicrobial Stewardship
March 15th 2017On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers from Rush University presented findings on the efficacy of a new guideline, which aimed to detect whether self-reported beta-lactam allergies were, in essence, unpleasant side-effects to the drugs.
Schuchat Warns Loss of DHHS Fund Could Have Profound Impact on Infectious Disease Prevention
March 14th 2017It has been reported that the new healthcare reform bill could eviscerate the US Department of Health and Human Service’s Prevention and Public Health Fund, which, among other things, funds roughly 12% of the Centers for Disease Control and Prevention’s budget.
Zika Linked with Cardiovascular Complications
March 14th 2017Researchers remind us that the Zika virus infection does not only cause complications in developing fetuses, after reports identified that nine patients from Venezuela presented with cardiovascular complications linked with the mosquito-borne infection.
Hepatitis C and the Dwindling of Research Funding
March 14th 2017Hepatitis C virus is the world’s most prevalent blood-borne viral infection for which a vaccine does not exist. To eliminate HCV infection on a global scale, experts argue that vaccine development needs to become a public health priority.
Beta-Lactam Allergy Linked to Worse Clinical Outcomes
March 13th 2017On March 5, 2017, at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI), Gary Huang, MD, PhD, explained his research team's findings regarding self-reported allergy to drugs containing β-lactams.
Doctors Without Borders Funds TB Research Amid Controversy on WHO Priority Pathogens List
March 13th 2017In late February, the World Health Organization (WHO) released its first list of Priority Pathogens, for which research and development is strongly needed. Not included on the list is tuberculosis, which has been acknowledged as one of the leading killers around the world. Naturally, many individuals working in public health and infectious disease are objecting to the exclusion.
National Women & Girls HIV/AIDS Awareness Day: Let's Break the Stigma
March 11th 2017March 10, 2017 marks the 12th observance of National Women and Girls HIV/AIDS Awareness Day, a day that is dedicated to raising awareness about the impact of HIV/AIDS on women and girls and encouraging them to take action when it comes to preventing infection.
No Correlation Found Between Asthma & the Development of Severe Dengue
March 10th 2017A group of researchers used data from St. Luke’s hospital network’s Sentinel Enhanced Dengue Surveillance Systems to investigate the association of asthma and the development of severe Dengue. Their findings were presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology.
Egyptian Initiative Aims to Create “A World Free of Hepatitis C”
March 10th 2017According to Tour n’ Cure, an Egyptian initiative that aims to rid the world of hepatitis C, Egypt aims to give program participants an opportunity to receive full treatment at an extremely low cost, while touring “the land that gave birth to the first great civilization.”
Chlamydia Vaccine: A Costly Solution to STD-Related Morbidity & Mortality
March 10th 2017At the 2017 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) in Atlanta, Georgia, researchers presented findings that suggested that a chlamydia vaccine, although costly, can avert significant morbidity.